Accompanied by Mr. Xuelin Yin (General Manager of Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd), Drs. Weiyi Zhang (External Innovation China Director), Hua Jiang (Associate Director, External Innovation) and Mengtao Xiao (Manager, External Innovation) from Boehringer Ingelheim (China) Investment Co., Ltd. visited the National Center for Drug Screening (NCDS) in the morning of March 13, 2019. They were warmly received by Professor Ming-Wei Wang (Director of the National Center for Drug Screening/CNCL). Both parties briefly introduced their areas of research and technical capabilities and discussed collaboration opportunities in R&D interest matching and joint talent training, reaching an agreement on the follow-up plans.